Press release
Global Pediatric Oncology Drugs Market Set to Transform Cancer Care for Children with Breakthrough Therapies 2025 | Top key players - US WorldMeds, Novartis, Bristol Myers Squibb.
Pediatric Oncology Drugs Market
Global Pediatric Oncology Drugs Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
Pediatric Oncology Drugs Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/pediatric-oncology-drugs-market?sz
The Pediatric Oncology Drugs Market refers to the segment of the pharmaceutical industry focused on developing and supplying medications for treating cancers in children and adolescents. It includes chemotherapy, targeted therapies, immunotherapies, and supportive drugs designed to improve survival rates, reduce side effects, and address the unique clinical needs of pediatric cancer patients worldwide.
Recent Key Developments of USA and Japan:
USA:
August 6, 2025: The FDA granted accelerated approval to dordaviprone (Modeyso) for pediatric patients 1 year of age and older with diffuse midline glioma.
May 14, 2025: Belzutifan (Welireg) received FDA approval for pediatric patients 12 years and older with locally advanced, unresectable, or metastatic pheochromocytoma or paraganglioma (PPGL).
Japan:
June 6, 2025: Japan's Pharmaceuticals and Medical Devices Agency (PMDA) announced regulatory support for pediatric drug development, including encouraging Japanese companies to join global clinical trials.
August 25, 2025: ENHERTU® was approved as the first HER2-directed medicine in Japan for patients with HER2-low or HER2-ultralow metastatic breast cancer, which may have implications for pediatric use as well.
Market Key Players:
US WorldMeds
Novartis
Bristol Myers Squibb
Pfizer Inc
ORPHELIA Pharma
Day One Pharmaceuticals
Celon Labs
United Therapeutics
Y-mAbs Therapeutics, Inc
Servier Pharmaceuticals LLC.
Growth Forecast Projected:
The Global Pediatric Oncology Drugs Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Pediatric Oncology Drugs Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=pediatric-oncology-drugs-market
Market Segmentation:
By Drug Type: Eflornithine [Iwilfin], Entrectinib [Rozlytrek], Nivolumab [Opdivo], Bosutinib [Bosulif], Dabrafenib [Tafinlar], Others.
By Indication: Leukemia, Lymphoma, Brain Tumors, Neuroblastoma, Wilms Tumor, Others.
By Route of Administration: Oral, Topical, Intravenous, Others.
By End User: Hospitals, Specialty Clinics, Cancer Research Institutes, Others.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/pediatric-oncology-drugs-market
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
➠ How big is the Pediatric Oncology Drugs market?
➠ Who are the key players in the Pediatric Oncology Drugs market?
➠ What is the projected growth rate of the Pediatric Oncology Drugs market?
➠ What is the market forecast for the Pediatric Oncology Drugs industry by 2033?
➠ Which region is estimated to dominate the Pediatric Oncology Drugs market through the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pediatric Oncology Drugs Market Set to Transform Cancer Care for Children with Breakthrough Therapies 2025 | Top key players - US WorldMeds, Novartis, Bristol Myers Squibb. here
News-ID: 4171263 • Views: …
More Releases from DataM Intelligence 4Market Research
Reactive Airway Disease Market Poised for Robust Growth Amid Rising Respiratory …
Market Overview:
The Global Reactive Airway Disease Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.
Reactive Airway Disease Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods,…
Targeted Therapy Market is expected to reach US$ 147.16 billion by 2033 | Top ke …
Market Size and Growth:
The Targeted Therapy Market reached US$ 79.18 billion in 2024 and is expected to reach US$ 147.16 billion by 2033, growing at a CAGR of 7.2% during the forecast period 2025-2033.
Targeted Therapy Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay…
Behavioral Health Market is expected to reach US$ 123.68 billion by 2033 | Emerg …
Market Size and Growth:
The Global Behavioral Health Market reached US$63.73 billion in 2024 and is expected to reach US$123.68 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033, according to DataM Intelligence report.
Behavioral Health Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make…
Idiopathic Pulmonary Fibrosis Market is expected to reach US$ 8.25 Billion by 20 …
Market Size and Growth:
The Global Idiopathic Pulmonary Fibrosis Market size reached US$ 4.24 Billion in 2024 from US$ 3.96 Billion in 2023 and is expected to reach US$ 8.25 Billion by 2033, growing at a CAGR of 7.7% during the forecast period 2025-2033.
Idiopathic Pulmonary Fibrosis Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence,…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
